Cargando…
Rejection of Mouse Renal Cell Carcinoma Elicited by Local Secretion of Interleukin‐2
We introduced the interleukin‐2 (IL‐2) gene into mouse renal cell carcinoma (RenCa) in order to examine the mechanism of tumor rejection. IL‐2 gene‐transfected RenCa (RenCa/IL‐2Hi) exhibited marked retardation of tumor growth when implanted in a syngeneic host. Growth retardation of RenCa/IL‐2Hi was...
Autores principales: | Hara, Isao, Hotta, Hak, Sato, Noriyuki, Eto, Hiroshi, Arakawa, Soichi, Kamidono, Sadao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921150/ https://www.ncbi.nlm.nih.gov/pubmed/8698622 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00284.x |
Ejemplares similares
-
Introduction of Clusterin Gene into Human Renal Cell Carcinoma Cells Enhances Their Resistance to Cytotoxic Chemotherapy through Inhibition of Apoptosis both in vitro and in vivo
por: Hara, Isao, et al.
Publicado: (2001) -
Optimal timing and dosage of chemotherapy as a combined treatment with androgen withdrawal in the human prostate LNCaP tumour model
por: Miyake, H, et al.
Publicado: (2001) -
Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells
por: Miyake, H, et al.
Publicado: (1999) -
Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection
por: Chen, XueDong, et al.
Publicado: (2011) -
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)